| Characteristics |
n (%) |
miR-205 expression |
Smad4 mRNA expression |
| Age |
|
|
|
| ≤65 |
23(44.2%) |
0.04636 ± 0.03018 |
0.01468 ± 0.005275 |
| >65 |
29(55.8%) |
0.02214 ± 0.005835 |
0.01613 ± 0.002599 |
| p value |
|
0.2542 |
0.3176 |
| Gender |
|
|
|
| Male |
35(67.3%) |
0.03881 ± 0.02009 |
0.01737 ± 0.003710 |
| Female |
17(32.7%) |
0.007869 ± 0.004414 |
0.02170 ± 0.004920 |
| pvalue |
|
0.2933 |
0.497 |
| Histology |
|
|
|
| Adenocarcinomas |
23(44.2%) |
0.002255 ± 0.001046 |
0.02318 ± 0.004031 |
| Squamous cell carcinomas |
21(40.4%) |
0.06717 ± 0.03249 |
0.01657 ± 0.005662 |
| Others |
8(15.4%) |
0.003701 ± 0.002517 |
0.01197 ± 0.003196 |
| pvalue |
|
0.0002 |
0.0118 |
| Smoking status |
|
|
|
| Yes |
29(55.8%) |
0.04599 ± 0.02409 |
0.01802 ± 0.004432 |
| No |
23(44.2%) |
0.006882 ± 0.003348 |
0.01976 ± 0.003768 |
| pvalue |
|
0.1577 |
0.7734 |
| Clinical stage |
|
|
|
| I |
14(26.9%) |
0.02205 ± 0.01011 |
0.01707 ± 0.004104 |
| II |
11(21.2%) |
0.005553 ± 0.003258 |
0.01591 ± 0.002582 |
| III |
21(40.4%) |
0.01759 ± 0.008529 |
0.02082 ± 0.006296 |
| IV |
6(11.5%) |
0.1255 ± 0.1127 |
0.02095 ± 0.009091 |
| pvalue |
|
0.7945 |
0.7752 |
|
